Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
576.49
-7.21 (-1.24%)
At close: Dec 3, 2025, 4:00 PM EST
577.00
+0.51 (0.09%)
Pre-market: Dec 4, 2025, 7:04 AM EST
Medpace Holdings Market Cap
Medpace Holdings has a market cap or net worth of $16.24 billion as of December 4, 2025. Its market cap has increased by 68.19% in one year.
Market Cap
16.24B
Enterprise Value
16.10B
1-Year Change
68.19%
Ranking
Category
Stock Price
$576.49
Market Cap Chart
Since August 11, 2016, Medpace Holdings's market cap has increased from $1.10B to $16.24B, an increase of 1,373.97%. That is a compound annual growth rate of 33.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 16.24B | 57.26% |
| Dec 31, 2024 | 10.33B | 9.79% |
| Dec 29, 2023 | 9.41B | 42.38% |
| Dec 30, 2022 | 6.61B | -15.55% |
| Dec 31, 2021 | 7.82B | 57.08% |
| Dec 31, 2020 | 4.98B | 64.41% |
| Dec 31, 2019 | 3.03B | 60.71% |
| Dec 31, 2018 | 1.88B | 38.21% |
| Dec 29, 2017 | 1.36B | -7.16% |
| Dec 30, 2016 | 1.47B | 33.32% |
| Aug 11, 2016 | 1.10B | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.62B |
| Johnson & Johnson | 497.33B |
| AbbVie | 397.04B |
| UnitedHealth Group | 295.87B |
| AstraZeneca | 283.73B |
| Merck & Co. | 254.61B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.71B |